Whitehawk Therapeutics Inc (WHWK) Stock Grade

About Whitehawk Therapeutics Inc's fundamentals

Whitehawk Therapeutics is a small-cap biotechnology company with a market capitalization of $149.8 million that is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -288.3%. The company experienced a significant revenue contraction of 72.5% year-over-year, indicating a substantial decline in sales. The company does not currently pay a dividend and lacks traditional profitability metrics such as a meaningful P/E ratio or positive return on equity, which is typical for early-stage or struggling biotech firms.